Business Wire

Veracyte Announces that New Data from Multiple Studies Demonstrate “Real World” Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis

Additionally, in two oral presentations, researchers shared the first “real world” Afirma Xpression Atlas data, providing insights into the distribution of a wide range of gene variants and fusions ...
Business Wire

Veracyte Announces Multiple Studies to Be Presented at ATA Annual Meeting Demonstrating “Real World” Performance of Afirma GSC and Xpression Atlas in Thyroid Cancer Diagnosis

SOUTH SAN FRANCISCO, Calif.-- (BUSINESS WIRE)-- Veracyte, Inc. (Nasdaq: VCYT) today announced that findings from six studies will be presented at the 88 th Annual Meeting of the American Thyroid ...